Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:34 PM
Ignite Modification Date:
2025-12-24 @ 7:34 PM
NCT ID:
NCT02155803
Eligibility Criteria:
Inclusion Criteria:
1. Age greater than 18 years old.
2. Able to understand English to the point of comprehending the informed consent form.
3. Biopsy proven sarcoidosis.
4. Documented hypercalciuria (urinary excretion of \> 4mg/kg of calcium/day) or hypercalcemia within 4 weeks of study entry.
5. Historical evidence that the patient's hypercalciuria/hypercalcemia is related to sarcoidosis. This should include a serum parathyroid hormone (PTH) level which is not elevated.
Exclusion Criteria:
1. A change in anti-sarcoidosis medications within 3 months of study entry.
2. A history of hyperparathyroidism or another non-sarcoidosis cause of hypercalcemia/hypercalciuria
3. A history of Cushing's disease.
4. Have a diagnosis of a medical disorder other than sarcoidosis that in the opinion of the investigator would complicate the evaluation of response treatment.
5. Have used any investigational drug within 1 month prior to screening or within 5 half-lives of the investigational agent, whichever is longer.
6. Use of loop or thiazide diuretics for hypertension or other disorders.
7. Chronic use of antacids.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02155803
Study Brief:
Protocol Section:
NCT02155803